PPLPHARMA
Piramal Pharma Limited
Pharmaceuticals
Share price
₹201
Market cap
₹26,634 Cr
1Y return
▲ 3%
A pharmaceutical company operating across three major segments: contract development and manufacturing organisations, complex hospital generics for critical care, and consumer healthcare products. Established through the acquisition of Nicholas Laboratories in 1988, the company has expanded via strategic mergers and acquisitions alongside organic growth initiatives. It serves healthcare providers and consumers across India through its diversified business operations and specialized pharmaceutical solutions.
Investors holding Piramal Pharma Limited
2.00%
Recent moves 3
Canara Robeco Mutual FundExited
Canara Robeco Mutual Fund, which last reported a 1.0 percent stake in Piramal Pharma Limited, is no longer on the list of disclosed shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund decreased its stake in Piramal Pharma Limited from 9.37% to 7.68%, selling 22,260,933 shares worth ₹386.58 Cr at ₹173.63 apiece.
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund decreased its stake in Piramal Pharma from 9.02% to 7.01%, selling 2,66,88,471 shares via open market on July 14, 2026.
Read more
Track the whales in Piramal Pharma Limited
Get alerted the moment a top investor buys or sells.
Get started